CSL to complete contracted manufacture of AstraZeneca vaccines in 2022
CSL has confirmed it will continue manufacturing AstraZeneca’s Covid-19 vaccine into next year, following reports it would cease production early due to local preferences for the Pfizer and Moderna vaccines. The full contract with the federal government to produce approximately 50 million doses of Vaxzevria will be met, with any unused doses donated to countries…